CH680512A5 - - Google Patents
Download PDFInfo
- Publication number
- CH680512A5 CH680512A5 CH3804/90A CH380490A CH680512A5 CH 680512 A5 CH680512 A5 CH 680512A5 CH 3804/90 A CH3804/90 A CH 3804/90A CH 380490 A CH380490 A CH 380490A CH 680512 A5 CH680512 A5 CH 680512A5
- Authority
- CH
- Switzerland
- Prior art keywords
- group
- resin
- alcohol
- peptide
- residue
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 43
- 229920005989 resin Polymers 0.000 claims description 29
- 239000011347 resin Substances 0.000 claims description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 14
- 229920000642 polymer Polymers 0.000 claims description 13
- 125000006239 protecting group Chemical group 0.000 claims description 13
- 125000003158 alcohol group Chemical group 0.000 claims description 9
- 210000004899 c-terminal region Anatomy 0.000 claims description 8
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims description 6
- 229920003002 synthetic resin Polymers 0.000 claims description 6
- 239000004793 Polystyrene Substances 0.000 claims description 5
- 229920002223 polystyrene Polymers 0.000 claims description 5
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000000057 synthetic resin Substances 0.000 claims description 4
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 238000005903 acid hydrolysis reaction Methods 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 abstract description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract description 5
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 230000008878 coupling Effects 0.000 abstract 2
- 238000010168 coupling process Methods 0.000 abstract 2
- 238000005859 coupling reaction Methods 0.000 abstract 2
- 239000007859 condensation product Substances 0.000 abstract 1
- 108091005601 modified peptides Proteins 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- 150000003254 radicals Chemical class 0.000 description 13
- 102000004196 processed proteins & peptides Human genes 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 10
- -1 polyethylene Polymers 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 125000004036 acetal group Chemical group 0.000 description 6
- 238000003776 cleavage reaction Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 230000007017 scission Effects 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 125000006850 spacer group Chemical group 0.000 description 5
- MUVQIIBPDFTEKM-QWWZWVQMSA-N (2r,3r)-2-aminobutane-1,3-diol Chemical group C[C@@H](O)[C@H](N)CO MUVQIIBPDFTEKM-QWWZWVQMSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 150000001414 amino alcohols Chemical class 0.000 description 4
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical group C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 3
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 2
- OYNIIKHNXNPSAG-UHFFFAOYSA-N 2-(4-formylphenoxy)acetic acid Chemical compound OC(=O)COC1=CC=C(C=O)C=C1 OYNIIKHNXNPSAG-UHFFFAOYSA-N 0.000 description 2
- JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 238000006359 acetalization reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 229960002684 aminocaproic acid Drugs 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000002952 polymeric resin Substances 0.000 description 2
- 229920005990 polystyrene resin Polymers 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- VVQIIIAZJXTLRE-QMMMGPOBSA-N (2s)-2-amino-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid Chemical compound CC(C)(C)OC(=O)NCCCC[C@H](N)C(O)=O VVQIIIAZJXTLRE-QMMMGPOBSA-N 0.000 description 1
- DEQANNDTNATYII-OULOTJBUSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-n-[(2r,3r)-1,3-dihydroxybutan-2-yl]-7-[(1r)-1-hydroxyethyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 description 1
- CFBPGADIXTVKBS-UHFFFAOYSA-N 2-amino-3-sulfanylpropan-1-ol Chemical group OCC(N)CS CFBPGADIXTVKBS-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- KJJPLEZQSCZCKE-UHFFFAOYSA-N 2-aminopropane-1,3-diol Chemical group OCC(N)CO KJJPLEZQSCZCKE-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 101800001415 Bri23 peptide Proteins 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- 102400000107 C-terminal peptide Human genes 0.000 description 1
- 101800000655 C-terminal peptide Proteins 0.000 description 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
- 108010016076 Octreotide Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000005521 carbonamide group Chemical group 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- VMVNZNXAVJHNDJ-UHFFFAOYSA-N methyl 2,2,2-trifluoroacetate Chemical compound COC(=O)C(F)(F)F VMVNZNXAVJHNDJ-UHFFFAOYSA-N 0.000 description 1
- AUNMDDDYIVMYNS-QWWZWVQMSA-N n-[(2r,3r)-1,3-dihydroxybutan-2-yl]-2,2,2-trifluoroacetamide Chemical compound C[C@@H](O)[C@@H](CO)NC(=O)C(F)(F)F AUNMDDDYIVMYNS-QWWZWVQMSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229960002700 octreotide Drugs 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000006894 reductive elimination reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical class C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- HNKJADCVZUBCPG-UHFFFAOYSA-N thioanisole Chemical compound CSC1=CC=CC=C1 HNKJADCVZUBCPG-UHFFFAOYSA-N 0.000 description 1
- TUQOTMZNTHZOKS-UHFFFAOYSA-N tributylphosphine Chemical compound CCCCP(CCCC)CCCC TUQOTMZNTHZOKS-UHFFFAOYSA-N 0.000 description 1
- 239000005051 trimethylchlorosilane Substances 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- FTVLMFQEYACZNP-UHFFFAOYSA-N trimethylsilyl trifluoromethanesulfonate Chemical compound C[Si](C)(C)OS(=O)(=O)C(F)(F)F FTVLMFQEYACZNP-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3634797 | 1986-10-13 | ||
| DE3634826 | 1986-10-13 | ||
| DE3634825 | 1986-10-13 | ||
| DE3712626 | 1987-04-14 | ||
| CH315387 | 1987-08-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH680512A5 true CH680512A5 (esLanguage) | 1992-09-15 |
Family
ID=27509117
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1353/89A CH682632A5 (de) | 1986-10-13 | 1987-10-12 | Mit Zuckerresten modifizierte Peptide. |
| CH3804/90A CH680512A5 (esLanguage) | 1986-10-13 | 1987-10-12 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1353/89A CH682632A5 (de) | 1986-10-13 | 1987-10-12 | Mit Zuckerresten modifizierte Peptide. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5656721A (esLanguage) |
| JP (2) | JPH0645639B2 (esLanguage) |
| KR (1) | KR960016861B1 (esLanguage) |
| AU (2) | AU617986B2 (esLanguage) |
| BE (1) | BE1003752A4 (esLanguage) |
| CA (1) | CA1340985C (esLanguage) |
| CH (2) | CH682632A5 (esLanguage) |
| DE (1) | DE3790635T1 (esLanguage) |
| DK (1) | DK174337B1 (esLanguage) |
| ES (1) | ES2007418A6 (esLanguage) |
| FI (1) | FI874495L (esLanguage) |
| FR (1) | FR2609991A1 (esLanguage) |
| GB (2) | GB2199829B (esLanguage) |
| GR (1) | GR871567B (esLanguage) |
| HU (3) | HU206890B (esLanguage) |
| IE (1) | IE912442A1 (esLanguage) |
| LU (1) | LU87014A1 (esLanguage) |
| NL (1) | NL194729C (esLanguage) |
| NZ (1) | NZ222133A (esLanguage) |
| PL (1) | PL157156B1 (esLanguage) |
| PT (1) | PT85904B (esLanguage) |
| SE (2) | SE8703938L (esLanguage) |
| WO (1) | WO1988002756A2 (esLanguage) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU206890B (en) * | 1986-10-13 | 1993-01-28 | Sandoz Ag | Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components |
| DE3822557C2 (de) * | 1987-07-10 | 1998-07-02 | Ciba Geigy Ag | Arzneimittel, enthaltend Somatostatine |
| EP0329295A1 (en) * | 1988-02-01 | 1989-08-23 | The Upjohn Company | Renin inhibiting peptides with polar end groups |
| GB2218102B (en) * | 1988-04-08 | 1992-09-16 | Sandoz Ltd | Calcitonin peptide derivatives |
| DE3910667A1 (de) * | 1988-04-11 | 1989-10-19 | Sandoz Ag | Peptidderivate |
| GB8813339D0 (en) * | 1988-06-06 | 1988-07-13 | Sandoz Ltd | Improvements in/relating to organic compounds |
| FR2638968B1 (fr) * | 1988-11-11 | 1994-10-07 | Sandoz Sa | Nouvelle utilisation therapeutique de la somatostatine et de ses analogues et derives |
| US5776894A (en) * | 1988-12-05 | 1998-07-07 | Novartis Ag | Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors |
| US5753627A (en) * | 1988-12-05 | 1998-05-19 | Novartis Ag | Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis |
| MY106120A (en) * | 1988-12-05 | 1995-03-31 | Novartis Ag | Peptide derivatives. |
| IT1229514B (it) * | 1989-01-30 | 1991-09-03 | Farmhispania S A A Montme | Glicoconiugati anfifilici sintetici per impiego neurologico. |
| DK111489D0 (da) * | 1989-03-08 | 1989-03-08 | Novo Nordisk As | Peptider |
| DE4206858A1 (de) * | 1992-03-05 | 1993-09-09 | Behringwerke Ag | Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel |
| IT1260156B (it) * | 1992-08-03 | 1996-03-28 | Fidia Spa | Derivati dell'acido neuraminico |
| TW263437B (esLanguage) * | 1992-09-24 | 1995-11-21 | Takeda Pharm Industry Co Ltd | |
| US5710244A (en) * | 1992-12-31 | 1998-01-20 | Labroo; Virender M. | Derivatized calcitonins |
| US5508387A (en) * | 1993-08-04 | 1996-04-16 | Glycomed Incorporated | Selectin binding glycopeptides |
| SI0788509T1 (en) * | 1993-08-09 | 2003-10-31 | Societe De Conseils De Recherches | Therapeutic peptide derivatives |
| US5556939A (en) * | 1994-10-13 | 1996-09-17 | Merck Frosst Canada, Inc. | TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications |
| US5632969A (en) * | 1994-10-13 | 1997-05-27 | Merck & Co., Inc. | N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications |
| JP3896430B2 (ja) * | 1996-07-15 | 2007-03-22 | アークレイ株式会社 | 糖化アミノ化合物の製造方法 |
| IL119029A0 (en) * | 1996-08-07 | 1996-11-14 | Yeda Res & Dev | Long-acting drugs and pharamaceutical compositions comprising them |
| EP0981364B1 (en) | 1997-05-13 | 2006-03-01 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Method and compositions for treating hyperlipidemia |
| EP0981363B1 (en) | 1997-05-13 | 2003-07-30 | Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) | Somatostatin agonists for decreasing body weight |
| US6004928A (en) * | 1997-05-13 | 1999-12-21 | Biomeasure, Incorporated | Method of treating hyperlipidemia |
| DE69943039D1 (de) * | 1998-02-13 | 2011-01-27 | Amylin Pharmaceuticals Inc | Neue verbindungen mit gemischter amylin aktivität |
| US5968903A (en) * | 1998-05-07 | 1999-10-19 | Biomeasure, Incorporated | Inhibition of H. pylori proliferation |
| US20050037490A1 (en) * | 1999-10-29 | 2005-02-17 | Lawrence Rosenberg | Medium for preparing dedifferentiated cells |
| AU2002254691B8 (en) * | 2001-04-23 | 2008-02-14 | Mallinckrodt Inc. | Tc and Re labeler radioactive glycosylated octreotide derivatives |
| DK2062914T3 (da) | 2001-06-08 | 2014-07-14 | Ipsen Pharma | Somatostatin-dopamin-chimære analoger |
| PT1480998E (pt) * | 2002-02-27 | 2007-02-28 | Ferring Bv | Intermediários e métodos para fazer heptapeptídeos análogos de oxitocina. |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| ATE458491T1 (de) | 2005-08-26 | 2010-03-15 | Univ Leland Stanford Junior | Verfahren zur behandlung von kopfschmerzen durch verabreichung von oxytocin |
| ATE549011T1 (de) | 2005-11-10 | 2012-03-15 | Chemi Spa | Formulierungen mit verzögerter freisetzung, die somatostatin-analoge wachstumshormoninhibitoren enthalten |
| WO2008011168A2 (en) * | 2006-07-21 | 2008-01-24 | Amgen Inc. | Glycosylated peptide antagonists of the bradykinin b1 receptor |
| WO2008095063A1 (en) | 2007-01-31 | 2008-08-07 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
| EP2508531B1 (en) | 2007-03-28 | 2016-10-19 | President and Fellows of Harvard College | Stitched polypeptides |
| US8785594B2 (en) | 2007-09-25 | 2014-07-22 | Glycom A/S | Glycoproteins and glycosylated cells and a method for the preparation of the same |
| JP5660898B2 (ja) * | 2007-11-09 | 2015-01-28 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | 経口投与用の抗炎症性キナ酸誘導体 |
| BRPI0915888E2 (pt) | 2008-06-12 | 2020-09-01 | Syntaxin Ltd | polipetídeo, seu método de ativação, sequência de ácido nucléico codificando o mesmo e seu uso |
| ES2732205T3 (es) | 2008-06-12 | 2019-11-21 | Ipsen Bioinnovation Ltd | Proteínas de fusión para uso en el tratamiento del cáncer |
| WO2010089757A2 (en) * | 2008-11-07 | 2010-08-12 | Usv Limited | An improved process for synthesis of cyclic octapeptide |
| GB0820970D0 (en) | 2008-11-17 | 2008-12-24 | Syntaxin Ltd | Suppression of cancer |
| CN103282510A (zh) | 2010-08-13 | 2013-09-04 | 爱勒让治疗公司 | 拟肽大环化合物 |
| RU2627184C2 (ru) | 2011-09-04 | 2017-08-03 | Глитек, Инк. | Гликозилированные полипептиды и лекарственные композиции, содержащие данные полипептиды |
| BR112014004784A2 (pt) | 2011-09-04 | 2017-03-21 | Glytech Inc | polipeptídeo glicosilado e composição de drogas contendo referido polipeptídeo |
| KR20140100937A (ko) | 2011-10-18 | 2014-08-18 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티도미메틱 거대고리 |
| WO2013123266A1 (en) | 2012-02-15 | 2013-08-22 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
| JP6450192B2 (ja) | 2012-02-15 | 2019-01-09 | エイルロン セラピューティクス，インコーポレイテッド | トリアゾール架橋した、およびチオエーテル架橋したペプチドミメティック大環状化合物 |
| WO2014071241A1 (en) | 2012-11-01 | 2014-05-08 | Aileron Therapeutics, Inc. | Disubstituted amino acids and methods of preparation and use thereof |
| ES2862125T3 (es) | 2013-06-13 | 2021-10-07 | Antisense Therapeutics Ltd | Terapia combinada para acromegalia |
| SG11201702223UA (en) | 2014-09-24 | 2017-04-27 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof |
| US11389473B2 (en) | 2015-01-07 | 2022-07-19 | Tonix Pharmaceuticals Holding Corp. | Magnesium-containing oxytocin formulations and methods of use |
| US10253067B2 (en) | 2015-03-20 | 2019-04-09 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
| SMT202500100T1 (it) | 2016-04-12 | 2025-05-12 | Tonix Pharma Ltd | Formulazioni di ossitocina contenenti magnesio e metodi d'uso |
| US20200353419A1 (en) | 2017-11-22 | 2020-11-12 | Dauntless 1, Inc. | Membrane emulsification device for microsphere creation |
| US20200281857A1 (en) | 2017-11-22 | 2020-09-10 | Dauntless 1, Inc. | Therapeutic compound formulations |
| WO2020005842A1 (en) | 2018-06-25 | 2020-01-02 | Dauntless 2, Inc. | Membrane emulsification device with impeller for microsphere creation |
| EP3956343A1 (en) | 2019-04-16 | 2022-02-23 | Bachem Holding AG | Manufacture of disulfide bonded peptides |
| CA3180317A1 (en) | 2020-04-17 | 2021-10-21 | The Trustees Of Indiana University | Small molecule antiviral drug treatment for human papillomavirus infections |
| US20230399373A1 (en) * | 2020-10-22 | 2023-12-14 | The Trustees Of Indiana University | Molecular designs of glucose-responsive and glucose-cleavable insulin analogues |
| WO2025229200A1 (en) | 2024-05-03 | 2025-11-06 | Bachem Holding Ag | Manufacture of disulfide bonded peptides |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4254023A (en) * | 1979-10-16 | 1981-03-03 | Pennwalt Corporation | Synthesis of peptide alcohols by the solid phase method |
| US4280953A (en) * | 1979-11-08 | 1981-07-28 | The Salk Institute For Biological Studies | Glycosylated analogs of somatostatin |
| ATE2512T1 (de) * | 1979-11-27 | 1983-03-15 | Sandoz Ag | Polypeptide, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die diese polypeptide enthalten, und ihre verwendung. |
| FR2522967B1 (fr) * | 1982-03-15 | 1986-03-07 | Anvar | Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant |
| US4483792A (en) * | 1982-11-17 | 1984-11-20 | Kim Wan S | Glycosylated insulin derivatives |
| US4444683A (en) * | 1982-11-17 | 1984-04-24 | University Of Utah | Glycosylated insulin derivatives |
| FR2546163B1 (fr) * | 1983-05-16 | 1987-10-09 | Centre Nat Rech Scient | Nouveaux derives acyles hydrosolubles de peptides ou d'amino-acides, leur preparation et leur application |
| FR2548673B1 (fr) * | 1983-07-05 | 1985-10-04 | Essilor Int | Polymeres supports de produits actifs relargables et leur procede de preparation |
| LU85269A1 (fr) * | 1984-03-26 | 1985-10-14 | Techland S A | Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux |
| US4564998A (en) * | 1984-10-19 | 1986-01-21 | Westinghouse Electric Corp. | Coil winding methods and apparatus |
| DE3439610A1 (de) * | 1984-10-30 | 1986-04-30 | Boehringer Mannheim Gmbh, 6800 Mannheim | Immunogene, verfahren zu deren herstellung sowie damit gewonnene antikoerper gegen glykosiliertes haemoglobin |
| EP0192611A3 (de) * | 1985-02-20 | 1988-05-11 | Ciba-Geigy Ag | Acylierte Hexosederivate und Verfahren zu ihrer Herstellung |
| JPS61264260A (ja) * | 1985-05-17 | 1986-11-22 | Rikagaku Kenkyusho | アルデヒド化多孔性高分子材料によるタンパク質の除去方法 |
| CA1337041C (en) * | 1985-10-09 | 1995-09-19 | Brett Alan Evans | Granular detergent compositions having improved solubility |
| SE8506094D0 (sv) * | 1985-12-20 | 1985-12-20 | Astra Laekemedel Ab | New antibacterial agents and intermediates therefor |
| JPS63165411A (ja) * | 1986-09-11 | 1988-07-08 | Tokyo Organ Chem Ind Ltd | アルデヒド基を有する架橋共重合体の製法 |
| JPS63165410A (ja) * | 1986-09-11 | 1988-07-08 | Tokyo Organ Chem Ind Ltd | アルデヒド基を有する架橋共重合体の製造方法 |
| HU206890B (en) * | 1986-10-13 | 1993-01-28 | Sandoz Ag | Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components |
| US4859736A (en) * | 1987-03-30 | 1989-08-22 | Ciba-Geigy Corporation | Synthetic polystyrene resin and its use in solid phase peptide synthesis |
| CH679045A5 (esLanguage) * | 1987-06-29 | 1991-12-13 | Sandoz Ag |
-
1987
- 1987-10-01 HU HU874432A patent/HU206890B/hu not_active IP Right Cessation
- 1987-10-01 NL NL8702345A patent/NL194729C/nl not_active IP Right Cessation
- 1987-10-01 HU HU906341A patent/HU906341D0/hu unknown
- 1987-10-01 HU HU906340A patent/HU906340D0/hu unknown
- 1987-10-07 FR FR8713949A patent/FR2609991A1/fr active Granted
- 1987-10-07 LU LU87014A patent/LU87014A1/fr unknown
- 1987-10-09 GB GB8723737A patent/GB2199829B/en not_active Expired - Lifetime
- 1987-10-09 BE BE8701187A patent/BE1003752A4/fr not_active IP Right Cessation
- 1987-10-12 AU AU79564/87A patent/AU617986B2/en not_active Ceased
- 1987-10-12 WO PCT/EP1987/000593 patent/WO1988002756A2/en not_active Ceased
- 1987-10-12 CH CH1353/89A patent/CH682632A5/de not_active IP Right Cessation
- 1987-10-12 KR KR1019870011265A patent/KR960016861B1/ko not_active Expired - Lifetime
- 1987-10-12 GR GR871567A patent/GR871567B/el unknown
- 1987-10-12 FI FI874495A patent/FI874495L/fi not_active Application Discontinuation
- 1987-10-12 PT PT85904A patent/PT85904B/pt unknown
- 1987-10-12 NZ NZ222133A patent/NZ222133A/xx unknown
- 1987-10-12 DK DK198705327A patent/DK174337B1/da not_active IP Right Cessation
- 1987-10-12 CH CH3804/90A patent/CH680512A5/de not_active IP Right Cessation
- 1987-10-12 JP JP62257047A patent/JPH0645639B2/ja not_active Expired - Lifetime
- 1987-10-12 SE SE8703938A patent/SE8703938L/ not_active Application Discontinuation
- 1987-10-12 PL PL1987268173A patent/PL157156B1/pl unknown
- 1987-10-12 DE DE19873790635 patent/DE3790635T1/de active Pending
- 1987-10-13 ES ES8702913A patent/ES2007418A6/es not_active Expired
- 1987-10-13 CA CA000549140A patent/CA1340985C/en not_active Expired - Lifetime
-
1988
- 1988-01-12 GB GB8800537A patent/GB2199831B/en not_active Expired - Lifetime
-
1990
- 1990-06-04 JP JP2147161A patent/JP2744910B2/ja not_active Expired - Lifetime
-
1991
- 1991-07-03 AU AU80150/91A patent/AU634664B2/en not_active Expired
- 1991-07-12 IE IE244291A patent/IE912442A1/en unknown
-
1993
- 1993-04-07 SE SE9301172A patent/SE518630C2/sv unknown
-
1994
- 1994-07-07 US US08/272,704 patent/US5656721A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH680512A5 (esLanguage) | ||
| DE69732640T2 (de) | Festphasen-peptidsynthese | |
| DE68913935T2 (de) | Verfahren zur Herstellung von Retro-Inverso-Peptiden und dessen Zwischenprodukte. | |
| DE69120821T2 (de) | Polyethylenglykol-Derivate für Festphasenanwendungen | |
| DE2256445B2 (de) | Heptapeptide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate | |
| DE2714141A1 (de) | Dipeptid-analoge und verfahren zu ihrer herstellung | |
| DE4306839A1 (de) | Tritylgruppe enthaltendes Festphasensystem, Verfahren zu seiner Herstellung und seine Verwendung in Festphasenreaktionen | |
| EP0394194A1 (de) | Geschützte Aminosäuren und Verfahren zu ihrer Herstellung | |
| EP0460446A1 (de) | Ein neues Kupplungsreagenz für die Peptidsynthese | |
| DD299189A5 (de) | Verfahren zur solubilisation von peptiden und verfahren zu ihrer synthese | |
| EP0523461A2 (de) | Verfahren zur Verseifung von Aminosäure-/Peptidestern | |
| EP0434708B1 (de) | Verfahren zur herstellung von dipeptiden mit n-terminalen nichtproteinogenen aminosäuren | |
| AT406680B (de) | Festphasensynthese von peptidalkoholen | |
| DE1248059B (de) | Verfahren zur Herstellung bradykininwirksamer Undeca- und Dodecapeptide | |
| CH658661A5 (de) | Peptidverbindungen. | |
| EP0295540B1 (de) | Allylische Seitenketten enthaltendes Festphasensystem, Verfahren zu seiner Herstellung und seine Verwendung in Festphasenreaktionen | |
| DE1795714A1 (de) | Neue fuer die peptidsynthese vorteilhafte harzartige verbindungen, verfahren zu ihrer herstellung und verwendung dieser verbindungen fuer peptidsynthesen | |
| WO2022117590A1 (de) | Iodtyrosin-derivate und verfahren zur herstellung von iodtyrosin-derivaten | |
| EP0135183B1 (de) | Verfahren zur Herstellung von Carbonsäureamidgruppen enthaltenden Verbindungen, insbesondere von Peptiden | |
| DE2807220A1 (de) | Peptide und ihre herstellung | |
| EP0207415B1 (de) | Verbrückungsreagenz, Verfahren zu seiner Herstellung und seine Anwendung | |
| DD298932A5 (de) | Verfahren zur herstellung von peptidalkoholen | |
| EP0516070B1 (de) | Geschützte Derivate des Tryptophans, Verfahren zu deren Herstellung und deren Verwendung | |
| CH677233A5 (en) | New sugar derivs. of biologically active peptide(s) | |
| EP0536710B1 (de) | Aminosäurederivate zur Peptidsynthese |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PFA | Name/firm changed |
Owner name: SANDOZ AG TRANSFER- NOVARTIS AG |
|
| PL | Patent ceased |